Skip to main content

PRELUDE CAPITAL MANAGEMENT, LLC

Position in ARWR — Arrowhead Pharmaceuticals, Inc.

CIK 1387508 NEW YORK, NY

Position in ARWR

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$954,105
+$57,376 QoQ
Shares Held
15,217
+12.7% QoQ
Ownership
0.011%
of shares outstanding
% of Portfolio
0.09%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
12 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in ARWR Over Time

Shares Held

Position Value (USD)

Derivatives in ARWR

reported options exposure · as of Dec 31, 2020
CallValue
$230,190
CallShares
3,000
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

PRELUDE CAPITAL MANAGEMENT, LLC holds $41,687,806 across 71 Biotechnology names.

# Ticker Company Shares Value (USD) Open

All Filings in ARWR

Export CSV
12 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $954,105 15,217
2025-12-31 $896,729 13,507
2025-09-30 $988,414 28,658
2024-12-31 $805,692 42,856
2024-09-30 $1,035,888 53,479
2024-06-30 $959,784 36,929
2024-03-31 $363,220 12,700
2021-06-30 $470,003 5,675
2020-12-31 $230,190 3,000
2020-09-30 $68,896 1,600
2020-06-30 $69,104 1,600
2020-03-31 $28,770 1,000